Abstract Benzaldehyde is the simplest aromatic aldehyde constituent of almonds and many fruits. Anticancer effect of Benzaldehyde was first reported in 1980, and multi-institutional clinical trials were performed in those days in Japan. However, trial was over without determination of effectiveness, only its’ safety was confirmed. The underlying mechanism why Benzaldehyde specifically suppresses growth of some particular cancer cells but not that of normal cells has not been elucidated. Therefore, we attempted to clarify the mechanism of anticancer effect of Benzaldehyde. We have previously reported that, in pancreatic cancer cell BxPC3 and in non-small cell lung cancer cell A549, Benzaldehyde inhibits PI3K/AKT/mTOR, STAT3, NFκB and ERK pathways, those are major signaling pathways activated in cancer cells. Effects of Benzaldehyde on multiple signaling pathways are found to be derived from regulation of 14-3-3 family proteins which interact with phosphorylation sites of various proteins of multiple signals. In BxPC3 cells, Benzaldehyde treatment reduced the phosphorylation levels of 14-3-3-binding sites. Moreover, we ectopically expressed seven isoforms of 14-3-3 in HEK293T cells and found that Benzaldehyde treatment significantly suppressed association of 14-3-3ζ with client proteins such as mTOR, Rictor, cRaf, STAT3 and FOXOs. The interaction of other isoforms of 14-3-3 with their client proteins was also partially reduced. But, the expression levels of those seven 14-3-3 isoforms were not significantly changed. Here we further analysis the Benzaldehyde-mediated 14-3-3ζ regulation, in HEK293 cells overexpressing 14-3-3ζ. Benzaldehyde significantly suppressed mTOR pathway while it was not observed in parental HEK293 cells. Furthermore, we performed pull down assay by using 14-3-3ζ GST tagged recombinant proteins and lysates of HEK293T and BxPC3 and found that Benzaldehyde treatment suppressed the interaction of 14-3-3ζ with cRaf, TSC2 and other 14-3-3ζ client proteins. From these data, we confirmed that Benzaldehyde is an inhibitor of the overexpressed 14-3-3ζ. Recent reports have shown that 14-3-3ζ is overexpressed in many cancers and acts as a signaling hub controlling the network of oncogenic pathways, suggesting that overexpressed 14-3-3ζ associates with carcinogenesis, metastasis and resistance for chemotherapy and radiation. Hence, Benzaldehyde is considered to be a new molecular target agent of 14-3-3ζ which promote and maintain cancer signals. Citation Format: Jun Saitoh, Hideyuki Saya. Benzaldehyde suppresses the binding activity of overexpressed 14-3-3ζ to multiple signaling proteins in cancer cells [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2017; 2017 Apr 1-5; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 3135. doi:10.1158/1538-7445.AM2017-3135